World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
32219
World Ranking
12142
National Ranking
468

Anton F. H. Stalenhoef publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Anton F. H. Stalenhoef sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 399 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Anton F. H. Stalenhoef D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Anton F. H. Stalenhoef sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 90 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Anton F. H. Stalenhoef is affiliated with Radboud University Medical Center in the Netherlands. Their research primarily focuses on HIV-related health complications and treatments, HIV/AIDS drug development and treatment, and broader HIV research and treatment.

Their work spans several fields of study including Medicine and Immunology and Microbiology, with specific subfields such as Emergency Medicine, Infectious Diseases, and Virology.

Among recent publications, Stalenhoef has contributed to a 2024 paper titled Cardiometabolic Differences in People Living with HIV Receiving Integrase Strand Transfer Inhibitors Compared to Non-nucleoside Reverse Transcriptase Inhibitors: Implications for Current ART Strategies, published in the journal Viruses.

  • W Vos
  • Nadira Vadaq
  • Vasiliki Matzaraki
  • Twan Otten
  • Albert L. Groenendijk

  • Viruses

Best Publications

  • Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

    Borge G. Nordestgaard;M. John Chapman;Steve E. Humphries;Henry N. Ginsberg

  • Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia

    John J.P. Kastelein;Fatima Akdim;Erik S.G. Stroes;Aeilko H. Zwinderman

  • Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

    Marina Cuchel;Eric Bruckert;Henry N. Ginsberg;Frederick J. Raal

  • The role of TNF-α in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk

    Calin Popa;Mihai G. Netea;Piet L.C.M. van Riel;Jos W.M. van der Meer

  • Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline.

    Lars Berglund;John D. Brunzell;Anne C. Goldberg;Ira J. Goldberg

  • Familial Hypercholesterolaemia in Children and Adolescents: Gaining Decades of Life by Optimizing Detection and Treatment

    Albert Wiegman;Samuel S. Gidding;Gerald F Watts;M John Chapman

  • Homozigot ailevi hiperkolesterolemi: klinisyenlerin tanıyı ve klinik yönetimi geliştirmelerine yönelik yeni anlayışlar ve rehberlik. Avrupa Ateroskleroz Derneği’nin Ailevi Hiperkolesterolemi Üzerine Uzlaşı Paneli yazılı görüşü

    Marina Cuchel;Eric Bruckert;Henry N. Ginsberg;Frederick J. Raal

  • Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

    P J Barter;C M Ballantyne;R Carmena;M Castro Cabezas

  • The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management

    Robert A. Hegele;Henry N. Ginsberg;M. John Chapman;Børge G. Nordestgaard

  • Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study

    Greetje J. de Grooth;Jan Albert Kuivenhoven;Anton F.H. Stalenhoef;Jacqueline de Graaf

  • Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance.

    Mihai G Netea;Leo A B Joosten;Eli Lewis;Dalan R Jensen

  • Improved measurement of low-density-lipoprotein susceptibility to copper-induced oxidation: application of a short procedure for isolating low-density lipoprotein.

    Henne A. Kleinveld;Heidi L. M. Hak-Lemmers;Anton F. H. Stalenhoef;Pierre N. M. Demacker

  • Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia

    Alan D. Attie;Ronald M. Krauss;Mark P. Gray-Keller;Alison Brownlie

  • Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype–phenotype relationship, and clinical outcome

    Barbara Sjouke;D. Meeike Kusters;Iris Kindt;Joost Besseling

  • Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively.

    Kangmo Lu;Mi Hye Lee;Starr Hazard;Angela Brooks-Wilson

  • TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans

    Bart Ferwerda;Matthew B. B. McCall;Santos Alonso;Evangelos J. Giamarellos-Bourboulis

  • Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands.

    A.H. Pijlman;R. Huijgen;S.N. Verhagen;B.P.M. Imholz

  • Engagement of fatty acids with toll‐like receptor 2 drives interleukin‐1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal–induced gouty arthritis

    Leo A. B. Joosten;Mihai G. Netea;Eleni Mylona;Marije I. Koenders

  • A review of CETP and its relation to atherosclerosis

    Greetje J de Grooth;Anke H E M Klerkx;Erik S G Stroes;Anton F H Stalenhoef

  • The expression of type III hyperlipoproteinemia: involvement of lipolysis genes

    Peter Henneman;Femke Van Der Sman-De Beer;Payman Hanifi Moghaddam;Petra Huijts

Frequent Co-Authors

Mihai G. Netea
Mihai G. Netea Radboud University
John J.P. Kastelein
John J.P. Kastelein University of Amsterdam
Dorine W. Swinkels
Dorine W. Swinkels Radboud University
Jos W. M. van der Meer
Jos W. M. van der Meer Radboud University Medical Center
Bart Jan Kullberg
Bart Jan Kullberg Radboud University
Leo A. B. Joosten
Leo A. B. Joosten Radboud University
Charles A. Dinarello
Charles A. Dinarello University of Colorado Anschutz Medical Campus
Eric J.G. Sijbrands
Eric J.G. Sijbrands Erasmus University Rotterdam
Marja-Riitta Taskinen
Marja-Riitta Taskinen University of Helsinki
Frank L.J. Visseren
Frank L.J. Visseren Utrecht University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a career in healthcare but are looking for alternatives or faster routes than a traditional medical degree, there are several flexible online options to explore. For those who hold a non-nursing bachelor’s degree, direct entry msn programs for non-nursing majors offer a streamlined pathway to become a nurse at the graduate level.

Students seeking accessible RN programs may benefit from learning about the easiest rn program to get into, which covers schools with flexible admission criteria and less competitive entry requirements.

Not all healthcare roles require hands-on patient care. Those interested in the administrative side can consider training at one of the best online medical billing and coding schools to enter a fast-growing field with excellent remote work opportunities.

Admission tests can also be a barrier for some applicants. If you’re exploring nursing schools, you may want to know, do you have to take a teas test for lpn? There are schools that do not require TEAS or HESI exams for entry, simplifying the process.

Best Scientists Citing Anton F. H. Stalenhoef

Recently Published Articles